Read Why Needham Reiterated Buy On fuboTV Despite Slashing Its Price Target By 67% Needham analyst Laura Martin saw fuboTV Inc (NYSE: FUBO) as an inexpensive way for public investors to participate in the U.S. Benzinga · Jul 6, 2022
Needham Slashes Revenue, Earnings Projections, Price Targets of Majority Semiconductor Stocks: Key Takeaways Needham analyst N. Quinn Bolton saw a slowdown in demand across most end markets coupled with several quarters of inventory purge is likely to significantly decrease semiconductor sales in C2H22 and 2023 from original base case estimates. Benzinga · Jul 5, 2022
Needham Maintains Buy Rating for CarGurus: Here's What You Need To Know Needham has decided to maintain its Buy rating of CarGurus (NASDAQ:CARG) and lower its price target from $40.00 to $32.00. Shares of CarGurus are trading up 0.42% over the last 24 hours, at $22.52 per share. A move to $32.00 would account for a 42.13% increase from the current share… Benzinga · Jul 5, 2022
Here's Why Accolade Shares Are Trading Higher Today Needham analyst Ryan MacDonald reiterated a Buy rating on Accolade, Inc (NASDAQ:ACCD) with a price target of $12. Following a problematic 4QF22, he noted that Accolade bounced back nicely in 1QF23 as the company beat management's initial outlook for FY23 revenue and adjusted EBITDA. While early in the selling season, ACCD won more new business in 1QF23 than… Benzinga · Jul 1, 2022
TikTok's Smaller US Rival Files For IPO Short video app Triller Inc has confidentially filed for an initial public offering with the U.S. SEC. Recently, Triller terminated its merger with video advertising software provider SeaChange International, Inc (NASDAQ:SEAC) when it shared plans to pursue an IPO with a potential listing under the ticker symbol "ILLR" by September. Also Read: Triller Merging With SeaChange International: What Investors Should… Benzinga · Jul 1, 2022
Why Did Needham Lift Price Target For Trevi? Yesterday Trevi Therapeutics Inc's (NASDAQ:TRVI) Phase 2b/3 trial (PRISM) evaluating Haduvio (nalbuphine ER) for prurigo nodularis (PN) successfully met the key primary and secondary endpoints. Needham writes that Haduvio had a quick onset of action, reaching stat sig at 6 weeks with efficacy that had yet to plateau at the wk-14 readout. Trevi… Benzinga · Jun 30, 2022
Analysts Still Believe Verrica's Ycanth Is Approvable Despite FDA Response Letter Verrica Pharmaceuticals Inc (NASDAQ:VRCA) held a Type A meeting with the FDA regarding the path forward for the resubmission and potential approval of Ycanth (VP-102) for molluscum contagiosum. HC Wainwright says VP-102 was approvable, and at the time of the Complete Response Letter (CRL), Verrica had already engaged a potential alternate solution supplier. It reiterates… Benzinga · Jun 29, 2022
Here's Why Needham Continues To See 105% Upside To Avalara Post Its Analyst Day Needham analyst Scott Berg attended Avalara, Inc's (NYSE: AVLR) virtual analyst day, in which the company highlighted new products and provided intermediate-term financial targets that beat expectations. Benzinga · Jun 29, 2022
Needham's Developer Checks For Wix.com Highlight Continued Funnel Weakness Needham analyst Bernie McTernan reiterated a Buy rating and $85 price target on Wix.com Ltd (NASDAQ:WIX) following a round of web developer checks. He spoke with 22 developers in the WIX Marketplace to shed light on the broader funnel. They did not indicate any improvement. Failure of the funnel to return puts his 2H'22E and… Benzinga · Jun 29, 2022
Thinking About Buying Stock Or Options In Robinhood Markets, Nio, Tesla Or Etsy? Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends. Here are the latest analyst rating updates for Robinhood Markets, Nio, Tesla and Etsy: Benzinga · Jun 27, 2022
Needham Remains Upbeat On DoorDash; Slashes Price Target By 29% Needham analyst Bernie McTernan maintained DoorDash, Inc (NYSE:DASH) with a Buy rating and lowered the price target from $140 to $100 (42% upside). He believes DASH could leverage its leadership position in restaurant delivery to become one of the leading, horizontal, on-demand, last-mile fulfillment providers in North America. Ultimately, he thinks DASH would be able… Benzinga · Jun 27, 2022
Analysts Hailed CarMax's Q1 Performance While Highlighting Concerns Analysts lauded CarMax Inc's (NYSE:KMX) Q1 beat while also pointing out the macro concerns. RBC Capital analyst Steven Shemesh maintained CarMax with an Outperform and raised the price target from $104 to $108 in a note titled, "F1Q'23 Follow-Up – Navigating Volatility Well." KMX's results were broadly in line with expectations, Shemesh noted. He expected the inflationary… Benzinga · Jun 27, 2022
Read Why Needham Is Bullish On This Pet Care Retailer Needham analyst Anna Andreeva upgraded Chewy Inc (NYSE:CHWY) to Buy from Hold with a price target of $55, implying a 44% upside. The analyst said the company had exceeded expectations in Q1 FY22 after missing consensus EBITDA for four quarters. Andreeva thinks the positive momentum continued in Q2 as the pet category was inelastic, with price increases sticking,… Benzinga · Jun 27, 2022
Benzinga · Jun 27, 2022 Etsy Shares Drop As Needham Downgrades Stock Citing Near-Term Risks Needham analyst Anna Andreeva downgraded Etsy, Inc (NASDAQ:ETSY) from Buy to Hold. While shares have lagged and some near-term volatility is arguably in the stock, she views the discretionary nature of the ETSY model as increasingly at risk in the near term. While visibility is low, she thought that consensus GMS and Sales estimates…
Benzinga · Jun 24, 2022 Needham Is Bullish On This Botox Equivalent Aesthetics Company Needham initiated coverage on Evolus Inc (NASDAQ:EOLS) with a price target of $18.00 (43% upside) and a Buy rating. Evolus is a pure-play aesthetics company focused on growing the presence of Jeuveau, its new neurotoxin product, in the approximately $3 billion global wrinkle treatment market. Jeuveau is a prescription medicine injected into muscles to improve…
Benzinga · Jun 24, 2022 Ad Industry's Biggest Conference Returns With New Winner: Find Out Who The advertising industry's biggest conference has returned with a new winner Amazon.com, Inc (NASDAQ: AMZN), after a two-year break, Bloomberg reports. Amazon occupied a portion of the beachfront at the annual Cannes Lions show with the "Amazon Port," its most extensive showcasing at the conference yet reflecting its growing significance. Tech companies like Alphabet Inc (NASDAQ:GOOG)…
Benzinga · Jun 22, 2022 Needham Expresses Bullishness On US Ride-Share Industry; Uber Remains On Conviction List Needham analyst Bernie Mcternan forecasted a 24% 3-year CAGR for U.S. ride-share bookings through 2025, down from the 45% CAGR in the three years heading into the pandemic. Company data, industry reports, and a proprietary survey of 500+ U.S. consumers supported the forecast.
Benzinga · Jun 21, 2022 Here's Why Needham Predicts Taboola Shares To Double Needham analyst Laura Martin reiterated Buy on Taboola.com Ltd (NASDAQ:TBLA) with a price target of $5 (95.3% upside). Martin cited the eMarketer report that advertising revenue on the Open Internet (excluding Walled Gardens like Amazon.com Inc (NASDAQ: AMZN), Meta Platforms Inc's (NASDAQ:META) Facebook, Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google, YouTube, Snap Inc (NYSE:SNAP), and Roku, Inc (NASDAQ:ROKU)) is about $40 billion in the U.S. and about…
Benzinga · Jun 21, 2022 Needham Sees Above 72% Upside In This Conviction List Stock; Here's Why Needham analyst Chris Pierce anticipated CarGurus, Inc (NASDAQ: CARG) leveraging its industry-leading traffic metrics over the long term to create a compelling end-to-end digital solution for independent brick and mortar car dealerships.
Benzinga · Jun 21, 2022 Needham Lists Four Trends Aced By This Netflix Spin Off Needham analyst Laura Martin saw Roku, Inc (NASDAQ: ROKU) as a pure-play way to invest in the growth of the U.S. over-the-top (OTT) and connected-TV (CTV) ecosystems.
Benzinga · Jun 17, 2022 Needham Remained Bullish On KLA Corp Post Investor Day - Read Why Needham hailed KLA Corp's (NASDAQ: KLAC) 2022 Investor Day in NYC in a note titled "Investor Day Reveals New 2026 Model Targeting Revenue of $14bn and EPS of $38."
Benzinga · Jun 17, 2022 Needham Considers It Futile For Meta To Compete With TikTok, YouTube, Amazon, Google Needham's Laura Martin said Meta Platforms Inc's (NASDAQ: META) falling brand value is a lead indicator for rising customer acquisition costs, churn levels, and declining pricing power.
Benzinga · Jun 17, 2022 Here's Why Needham Sees Apple's Brand Value Worth At $1T Needham analyst Laura Martin believes lifetime value (LTV) is the primary driver of upside value for Apple Inc (NASDAQ: AAPL) and that brand value is a leading indicator of LTV in a note titled "AAPL's Brand is Worth $1 Trillion."
Benzinga · Jun 16, 2022 Needham Lists Its Top Picks After Attending Fiber Connect 2022 Conference Needham analysts Ryan Koontz and Chad Tevebaugh attended the Fiber Connect 2022 conference in Nashville. They heard from U.S. operators and met with many public and private companies in the broadband access space.